Alzheimer's disease, a progressive neurodegenerative condition, is characterized by a
gradual decline in cognitive functions. Current treatment approaches primarily involve the …

Carbon nanodots are zero-dimensional spherical allotropes of carbon and are less than
10nm in size (ranging from 2-8nm). Based on their biocompatibility, remarkable water …

Nanoparticles (NPs) based therapies for Alzheimer's disease (AD) attract interest due to
their ability to pass across or bypass the blood‐brain barrier. Chitosan (CS) NPs or …

In the present study a pH/ultrasound (US)-responsive nano-carriers based on magnetic core-
shell ZnFe 2 O 4@ mZnO@ GQDs and ZnFe 2 O 4@ mZnO@ N-GQDs ternary composite …

Zero-dimensional graphene quantum dots (GQDs) exhibit many different properties, such as
strong fluorescence, nonzero bandgap and solubility in solvents, compared to two …

There are currently approximately 50 million victims of Alzheimer's disease (AD) worldwide.
The exact cause of the disease is unknown at this time, but amyloid plaques and …

Nanotechnology has been utilized in developing novel drug formulations with minimal
adverse effects. Nanoparticles in a lower size range with great surface area, increased …

The excellent biocompatible and monodispersed gold nanoparticles (AuNPs) functionalized
by amino based ionic liquid (IL) have been synthesized for the demonstration of their …

Alzheimer's Disease is a complex progressive neurodegenerative disorder characterized by
neurofibrillary tangles and senile plaques in various parts of the brain particularly cerebral …

Inhibiting the formation of amyloid fibrils is a crucial step in the prevention of the human
neurological disorder, Alzheimer's disease (AD). Ionic liquid (IL) mediated interactions are …